Shaily Engineering Plastics Limited — Investor Meet, 17-02-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Financial Performance: Shaily Engineering Plastics reported a strong revenue growth of 25% year-over-year, totaling INR 197.6 crore for Q3 FY25. EBITDA surged 40% to INR 46.3 crore, with a corresponding EBITDA margin improvement to 23.4%, reflecting enhanced operational efficiency, primarily driven by a 62% growth in the Healthcare segment. PAT surged 73% to INR 25.2 crore, resulting in a PAT margin of 12.8%.

Future Outlook and Growth Drivers: Management highlighted a strategic focus on expanding the medical device business, projected to contribute 30% of revenues over the next three years. New contract wins in Healthcare and expanding global market reach through subsidiaries like Shaily Innovations in Dubai were emphasized.

Order Book and Operational Updates: Shaily reported positive developments with six new healthcare contracts for pen injectors and auto-injectors. Healthcare revenues are anticipated to rise due to newly established business from two global retail chains.

Analyst Q&A Insights: Analysts raised concerns about potential tariff impacts from the U.S. and execution timelines for new contracts. Management displayed confidence, citing ongoing discussions with customers regarding volume commitments while acknowledging geopolitical challenges. Capital allocation discussions indicated plans for facility expansions to meet anticipated demand for insulin-related products.

Market or Regulatory Updates: No significant regulatory concerns were discussed, but a known potential for U.S. tariffs was acknowledged as a market risk.

Strategic Focus Areas: The management is strategically focusing on innovation in the medical device sector and enhancing their operational capacity to meet new market demands.

Investor Insight: Given the solid revenue growth, improving profit margins, and strategic focus on high-growth sectors like healthcare, the financial health and growth trajectory suggest a ‘buy’ position to capitalize on future opportunities.